Log in to save to my catalogue

Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster...

Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10127164

Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model

About this item

Full title

Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model

Publisher

Tokyo: Springer Japan

Journal title

Journal of antibiotics, 2023-08, Vol.76 (8), p.481-488

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

COVID-19, caused by SARS-CoV-2 infection, is currently among the most important public health concerns worldwide. Although several effective vaccines have been developed, there is an urgent clinical need for effective pharmaceutical treatments for treatment of COVID-19. Ivermectin, a chemical derivative of avermectin produced by
Streptomyces ave...

Alternative Titles

Full title

Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10127164

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10127164

Other Identifiers

ISSN

0021-8820

E-ISSN

1881-1469

DOI

10.1038/s41429-023-00623-0

How to access this item